Código QR (código de barras bidimensional)

FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

ver descrição completa

Na minha lista:
Principais autores: Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2025-01-01
coleção:Cancer Medicine
Assuntos:
FXYD3
MAT‐8
pancreatic cancer
pancreatic ductal adenocarcinoma
prognosis
survival
Acesso em linha:https://doi.org/10.1002/cam4.70500
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados